Please login to the form below

Not currently logged in
Email:
Password:

Durbin appoints US business development principal

Todd Galles now takes up the role on a permanent basis

Durbin Todd GallesSpecialist medical supplier Durbin has appointed Todd Galles as its business development principal in the US in a permanent capacity.

Galles first joined the UK-headquartered firm in 2014, serving as its US representative in a part-time role, and will now be responsible for growing its clinical trial supply and managed access business there.

He brings over 30 years of sales, marketing and business development experience in the pharma and biotech industries, and has held a number of executive management roles during this time.

Prior to joining Durbin, Galles served as director of business development at C3 Research Associates, business development US liaison for Japanese contract research organisation CMIC, and business development director at US firm BDC.

He also brings experience from dermatology CRO bioskin, medical device and biotech CRO Boston Biomedical Associates, and clinical and data management firm ProPharma Group.

Robert Donnell, head of business development at Durbin, said: “Todd has supported business development outreach in the US part-time for Durbin for more than two years, so now we're delighted to have him on-board full-time.

“Todd brings a huge amount of experience and enthusiasm to the role, and I look forward to continuing to work with him to develop and grow our US business.”

26th September 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics